This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on Top Healthcare Stocks: IQVIA Holdings (IQV), Lantheus (LNTH)

Tipranks - Wed May 27, 7:40AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on IQVIA Holdings (IQV) and Lantheus (LNTH) with bullish sentiments.

Memorial Day Sale – Claim 70% Off TipRanks

IQVIA Holdings (IQV)

Truist Financial analyst Jailendra Singh maintained a Buy rating on IQVIA Holdings today. The company’s shares closed last Friday at $167.90.

According to TipRanks.com, Singh is ranked 0 out of 5 stars with an average return of -12.5% and a 35.7% success rate. Singh covers the Healthcare sector, focusing on stocks such as Hinge Health, Inc. Class A, Fortrea Holdings Inc., and Revolution Medicines. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for IQVIA Holdings with a $216.00 average price target, representing a 28.0% upside. In a report issued on May 13, Bank of America Securities also maintained a Buy rating on the stock with a $245.00 price target.

See today’s best-performing stocks on TipRanks >>

Lantheus (LNTH)

In a report released today, Richard Newitter from Truist Financial maintained a Buy rating on Lantheus. The company’s shares closed last Friday at $103.00.

According to TipRanks.com, Newitter is a 4-star analyst with an average return of 6.8% and a 47.2% success rate. Newitter covers the Healthcare sector, focusing on stocks such as Treace Medical Concepts, Inspire Medical Systems, and Zimmer Biomet Holdings. ;'>

Lantheus has an analyst consensus of Strong Buy, with a price target consensus of $101.57, a 7.6% upside from current levels. In a report released yesterday, TipRanks – PerPlexity also reiterated a Buy rating on the stock with a $118.00 price target.

Read More on IQV:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.